Regeneron Pharmaceuticals (REGN) Net Equity Issued and Repurchased (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded Net Equity Issued and Repurchased of $49.2 million in Q2 2026, up 56.2% from $31.5 million a year earlier but down 69.8% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' Net Equity Issued and Repurchased came in at $756.1 million as of Jun 30, 2026, up 72.7% year-over-year; for FY2025, it came in at $635.9 million, down 56.6% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -24.4% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $1.47 billion in FY2024 (+27.9%), $1.15 billion in FY2023 (-24.6%), $1.52 billion in FY2022 (-9.1%) and $1.67 billion in FY2021 (-35.1%).
- Quarterly Net Equity Issued and Repurchased has ranged from $31.5 million in Q2 2025 to $821.4 million in Q3 2021 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased has increased for three consecutive quarters, with growth averaging 42.0% over the last eight quarters.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 453.9% in Q4 2025, against a decline of 92.8% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $163.1 million (Q1 2026), $503.5 million (Q4 2025) and $40.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | -1.12 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.12 Bn |
| Mar 31, 2026 | -631.20 Mn |
| Dec 31, 2025 | -168.20 Mn |
| Sep 30, 2025 | -623.70 Mn |
| Jun 30, 2025 | -1.03 Bn |
| Mar 31, 2025 | -980.80 Mn |
| Dec 31, 2024 | -882.10 Mn |
| Sep 30, 2024 | -480.40 Mn |
| Jun 30, 2024 | -166.30 Mn |
| Mar 31, 2024 | 390.80 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | -277.90 Mn |
| Jun 30, 2023 | -598.10 Mn |
| Mar 31, 2023 | -225.50 Mn |
| Dec 31, 2022 | -58.50 Mn |
| Sep 30, 2022 | -616.10 Mn |
| Jun 30, 2022 | -52.20 Mn |
| Mar 31, 2022 | 163.50 Mn |
| Dec 31, 2021 | -324.20 Mn |
| Sep 30, 2021 | 655.00 Mn |
API Access
Regeneron Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();